Walleye Trading LLC Dynavax Technologies Corp Put Options Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $1,170 - $1,498	100 New	100 $1,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $182,806 - $236,561	17,800 Added 237.33%	25,300 $269,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $68,517 - $120,336	6,900 Added 1150.0%	7,500 $78,000
Q2 2022 Aug 08, 2022	SELL	$7.45 - $12.83 $70,030 - $120,602	-9,400 Reduced 94.0%	600 $8,000
Q1 2022 May 16, 2022	SELL	$9.75 - $14.44 $3,900 - $5,776	-400 Reduced 3.85%	10,000 $108,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $584,748 - $929,736	-44,400 Reduced 81.02%	10,400 $146,000
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $171,292 - $370,820	18,700 Added 51.8%	54,800 $1.05 Million
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $149,350 - $226,394	-20,600 Reduced 36.33%	36,100 $356,000
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $257,291 - $629,434	56,300 Added 14075.0%	56,700 $557,000
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $1,492 - $2,240	400 New	400 $2,000
Q1 2019 May 15, 2019	SELL	$7.08 - $12.09 $141,600 - $241,800	-20,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.14 - $13.28 $162,800 - $265,600	20,000 New	20,000 $183,000

274

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.